Austco Healthcare Valuation
| AHC Stock | 0.31 0.01 3.33% |
Austco Healthcare seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Austco Healthcare from analyzing the firm fundamentals such as Current Valuation of 95.62 M, return on equity of 0.2, and Profit Margin of 0.12 % as well as examining its technical indicators and probability of bankruptcy.
Price Book 2.4201 | Enterprise Value 95.6 M | Enterprise Value Ebitda 11.9346 | Price Sales 1.9094 | Trailing PE 15.25 |
Overvalued
Today
Please note that Austco Healthcare's price fluctuation is out of control at this time. Calculation of the real value of Austco Healthcare is based on 3 months time horizon. Increasing Austco Healthcare's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Austco Healthcare's intrinsic value may or may not be the same as its current market price of 0.31, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.31 | Real 0.25 | Hype 0.3 | Naive 0.29 |
The intrinsic value of Austco Healthcare's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Austco Healthcare's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Austco Healthcare helps investors to forecast how Austco stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Austco Healthcare more accurately as focusing exclusively on Austco Healthcare's fundamentals will not take into account other important factors: Austco Healthcare Cash |
|
Austco Healthcare Total Value Analysis
Austco Healthcare is presently forecasted to have takeover price of 95.62 M with market capitalization of 111.04 M, debt of 1.78 M, and cash on hands of 4.67 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Austco Healthcare fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
95.62 M | 111.04 M | 1.78 M | 4.67 M |
Austco Healthcare Investor Information
About 40.0% of the company shares are held by company insiders. The book value of Austco Healthcare was presently reported as 0.12. The company last dividend was issued on the 2nd of March 2023. Austco Healthcare had 1:1 split on the 28th of February 1989. Based on the measurements of operating efficiency obtained from Austco Healthcare's historical financial statements, Austco Healthcare is performing exceptionally good at this time. It has a great probability to report excellent financial results in March.Austco Healthcare Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Austco Healthcare has an asset utilization ratio of 84.64 percent. This implies that the Company is making USD0.85 for each dollar of assets. An increasing asset utilization means that Austco Healthcare is more efficient with each dollar of assets it utilizes for everyday operations.Austco Healthcare Ownership Allocation
Austco Healthcare holds a total of 364.06 Million outstanding shares. Austco Healthcare retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Austco Healthcare Profitability Analysis
The company reported the revenue of 58.15 M. Net Income was 7.08 M with profit before overhead, payroll, taxes, and interest of 30.67 M.About Austco Healthcare Valuation
The stock valuation mechanism determines Austco Healthcare's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Austco Healthcare based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Austco Healthcare. We calculate exposure to Austco Healthcare's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Austco Healthcare's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 35.3 M | 37 M |
Additional Tools for Austco Stock Analysis
When running Austco Healthcare's price analysis, check to measure Austco Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Austco Healthcare is operating at the current time. Most of Austco Healthcare's value examination focuses on studying past and present price action to predict the probability of Austco Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Austco Healthcare's price. Additionally, you may evaluate how the addition of Austco Healthcare to your portfolios can decrease your overall portfolio volatility.